John damonti
Foundation President @ Bristol-Myers Squibb
New York, United States
John damonti is a grant investor at Bristol-Myers Squibb in New York focused on Health Care and Hospital. John damonti - Foundation President @ Bristol-Myers Squibb
- Total investments:
- 4
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries John damonti invests in
Stages John damonti invests in
Countries John damonti invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 3 (75%)
- Hospital 2 (50%)
- Medical Device 2 (50%)
- Adult 1 (25%)
- Medical 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Penn Medicine Princeton Cancer Center
|
Penn Medicine Princeton Cancer Center provides access to the specialist clinical services, rehabilitative care, and support required during cancer treatment and recovery from cancer. | $2.5M / Grant / Mar 23, 2023 | |
Avera Medical Group
|
Avera Medical Group offers healthcare services in the areas of behavioral health, cancer care, cardiology, pediatrics, emergency and trauma, surgery, neuroscience, women's health, and other healthcare services. | $1.6M / Grant / Feb 20, 2018 | |
Jefferson Health System
|
Jefferson Health System is a health care company that offers an extended care community for personal health. | $2.8M / Grant / Dec 18, 2017 | |
University of North Carolina at Chapel Hill School of Medicine
|
The University of North Carolina School of Medicine is a professional school within the University of North Carolina at Chapel Hill. It offers degrees in the fields of medicine, allied health sciences, and biomedical sciences, as well as combined degree programs like the MD/PhD, MD/MPH, and the MD/MBA. It is on a mission to improvethe health and wellbeing of North Carolinians and others whom it serves by providing leadership and excellence in the interrelated areas of patient care, education, and research. The educational institution strives to promote faculty, staff, and learner development in a diverse, respectful environment where colleagues demonstrate professionalism, enhance learning, and create personal and professional sustainability. | $1.7M / Grant / Sep 29, 2017 |
About Bristol-Myers Squibb
Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products.
Bristol-Myers Squibb Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
John damonti
Foundation President
|
|||
Chris Boerner
Executive Vice President, Chief Commercialization Officer
|
|||
Debra Boyko-DeBrito
Director Content Management Solutions
|
|||
Donald J. Hayden, Jr.
President
|
|||
Doug Bassett
SVP Informatics & Predictive Sciences
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does John damonti invest in?
John damonti invests primarily in Health Care, Hospital and Medical Device startups, most often at Grant stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact John damonti?
Public channels for John damonti include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did John damonti last invest?
The most recent investment recorded for John damonti closed in Mar 2023. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
